Patient-Powered
Research Registry
Empower Your Participants and Drive Engagement
The Power of Patient Engagement
Greenphire’s Patient-Powered Research Registry allows for the creation of personalized patient registries to drive digital study success. Our unique participant-focused mobile application and assets enable organizations to develop interactive and informative content to further engage participants.
Greenphire’s experience and focus on innovation, participant engagement, and regulatory compliance will help deliver deeper insights and best practices that ensure clients are most effectively addressing recruitment and retention challenges.
Download the Registry Product Sheet
Core Solution Features
Experience the difference that our unique feature set offers:
eConsent:
Remotely consent research participants using our layered consent approach
Data Collection:
Collect participant-reported information via surveys and timelines
Insights:
Send participants updates on registry findings, educational information and event listings and details
Regulatory Review Support:
Enable rapid reviews by IRBs and Security Officers via our automation and assets
Access Across Platforms:
Offer participants an unmatched experience on their preferred device (iOS, Android, web)
Trial Identification (Optional):
Through our trial matching partner, automatically notify participants of relevant clinical studies
MBCA Bolsters Patient Engagement and Data Insights with Greenphire’s Patient-Powered Research Registry
The Metastatic Breast Cancer Alliance selected Greenphire’s Patient-Powered Research Registry as the platform for creating MBC Connect™ Patient Experience registry. They chose our platform based on technical expertise, solution flexibility, dynamic content creation, and the ability to derive unique analytics.
Download the full case study to read more.
Download Now
Improve Participant Engagement
Streamline Operations
Gain Research Insights
Innovate Rapidly
Maintain Compliance
“Having a tool that regularly provides helpful and relevant information, along with sharing trials that patients may be eligible for, is critically important.”
Laurie Campbell, Executive Director, MBC Alliance
